Your search returned 72 studies. (Get alerts for new studies):
- Growth of Infants Fed an Extensively Hydrolyzed Infant Formula
Conditions: Growth
Location: Newburgh, Indiana
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Owensboro, Kentucky
- Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Conditions: Asthma
Location: Owensboro, Kentucky
- Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
Conditions: Attention Deficit/Hyperactivity Disorder
Location: Madisonville, Kentucky
- Open-label Extension Evaluating Methylphenidate Hydrochloride Modified Release in Adults With Attention Deficit/Hyperactivity Disorder
Conditions: Attention Deficit/Hyperactivity Disorder
Location: Owensboro, Kentucky
- Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate
Conditions: Rheumatoid Arthritis
Location: Bowling Green, Kentucky
- Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthriti
Conditions: Rheumatoid Arthritis
Location: Bowling Green, Kentucky
- A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients
Conditions: Rheumatoid Arthritis
Location: Owensboro, Kentucky
- Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
Conditions: Acute Gouty Arthritis
Location: Owensboro, Kentucky
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Bowling Green, Kentucky
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Owensboro, Kentucky
- Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Location: Bowling Green, Kentucky
- Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Secukinumab P
Conditions: Moderate to Severe Chronic Plaque-Type Psoriasis
Location: Owensboro, Kentucky
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Springfield, Tennessee
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Owensboro, Kentucky
- Longitudinal Surveillance Registry (LSR) of ACUITY Spiral
Conditions: Heart Failure
Location: Bowling Green, Kentucky
- This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
Conditions: Heart Failure With Reduced Ejection Fraction
Location: Springfield, Tennessee
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Bowling Green, Kentucky
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Owensboro, Kentucky
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Owensboro, Kentucky
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Madisonville, Kentucky
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Owensboro, Kentucky
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Owensboro, Kentucky
- A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus - Connective Tissue Disease - Autoimmune Disease
Location: Bowling Green, Kentucky
- Growth of Infants Fed an Extensively Hydrolyzed Infant Formula
Conditions: Growth
Location: Owensboro, Kentucky
- Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment o
Conditions: Influenza
Location: Owensboro, Kentucky
- A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001 AM2)
Conditions: Clostridium Difficile Infection
Location: Owensboro, Kentucky
- Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3)
Conditions: Bipolar Disorder, Pediatric
Location: Owensboro, Kentucky
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma - Stage IIIB Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
Location: Owensboro, Kentucky
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Owensboro, Kentucky
- A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Conditions: Common Warts
Location: Owensboro, Kentucky
- Smoking Cessation Study In Healthy Adolescent Smokers
Conditions: Smoking Cessation
Location: Owensboro, Kentucky
- Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
Conditions: Influenza, Human
Location: Owensboro, Kentucky
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Madisonville, Kentucky
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Owensboro, Kentucky
- A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Conditions: Cardiovascular Disease, Rheumatoid Arthritis
Location: Bowling Green, Kentucky
- A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Conditions: Cardiovascular Disease, Rheumatoid Arthritis
Location: Owensboro, Kentucky
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: Owensboro, Kentucky
- Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 1 Year of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Location: Bowling Green, Kentucky
- Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
Conditions: Low Back Pain
Location: Madisonville, Kentucky
- A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opi
Conditions: Low Back Pain
Location: Madisonville, Kentucky
- SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Conditions: Major Depressive Disorder
Location: Owensboro, Kentucky
- Vest Prevention of Early Sudden Death Trial and VEST Registry
Conditions: Myocardial Infarction - Ventricular Dysfunction - Sudden Death - Ventricular Tachycardia - Ventricular Fibrillation
Location: Bowling Green, Kentucky
- Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Conditions: Chronic Gout
Location: Owensboro, Kentucky
- A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Conditions: Asthma
Location: Owensboro, Kentucky
- Stepped Enhancement of PTSD Services Using Primary Care (STEPS UP): A Randomized Effectiveness Trial
Conditions: Posttraumatic Stress Disorder (PTSD) - Depression
Location: Fort Campbell, Kentucky
- A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Conditions: Irritable Bowel Syndrome
Location: Bowling Green, Kentucky
- A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Pati
Conditions: Stable Atherothrombotic Disease
Location: Madisonville, Kentucky
- Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
Conditions: Irritable Bowel Syndrome With Diarrhea
Location: Bowling Green, Kentucky
- Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
Conditions: Irritable Bowel Syndrome With Diarrhea
Location: Madisonville, Kentucky
- Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
Conditions: Attention-deficit/Hyperactivity Disorder
Location: Owensboro, Kentucky
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Hawesville, Kentucky
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Madisonville, Kentucky
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Owensboro, Kentucky
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Bowling Green, Kentucky
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Owensboro, Kentucky
- Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain
Conditions: Chronic Low Back Pain
Location: Madisonville, Kentucky
- An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Spec
Conditions: Autism Spectrum Disorder (ASD) - Autism - Autistic Disorder - Asperger's Disorder - Asperger's - Pediatric Autism - Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) - Pervasive Child Development Disorder
Location: Owensboro, Kentucky
- Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis
Conditions: Relapsing Remitting Multiple Sclerosis
Location: Madisonville, Kentucky
- Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis
Conditions: Relapsing Remitting Multiple Sclerosis
Location: Owensboro, Kentucky
- A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)
Conditions: Psoriasis
Location: Owensboro, Kentucky
- A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB in Patients With COPD Who Have Moderate to Severe
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Location: Bowling Green, Kentucky
- Long Term Safety Study of NVA237 vs QAB149 in COPD Patients
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Location: Madisonville, Kentucky
- Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P
Conditions: Rhinitis, Allergic, Perennial - Rhinitis, Allergic, Nonseasonal
Location: Owensboro, Nebraska
- Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
Conditions: Moderate to Severe Plaque Psoriasis
Location: Owensboro, Kentucky
- A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
Conditions: Cardiovascular Disease, Diabetes Mellitus, Type 2
Location: Owensboro, Kentucky
- The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Conditions: Irritable Bowel Syndrome Characterized by Constipation
Location: Owensboro, Kentucky
- Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
Conditions: Asthma
Location: Bowling Green, Kentucky
- Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
Conditions: Asthma
Location: Owensboro, Kentucky
- Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
Conditions: Pulmonary Hypertension - Chronic Obstructive Pulmonary Disease
Location: Bowling Green, Kentucky
- Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Conditions: Dyslipidemia
Location: Owensboro, Kentucky
- A Dose-ranging Study of Fluticasone Furoate (FF)
Conditions: Asthma
Location: Owensboro, Kentucky
|